title: Screening for Fabry disease in patients with left ventricular hypertrophy.
authors.forename: Kazutoshi
authors.initials: K
authors.lastname: Mawatari
authors.forename: Hideo
authors.initials: H
authors.lastname: Yasukawa
authors.forename: Toyoharu
authors.initials: T
authors.lastname: Oba
authors.forename: Takanobu
authors.initials: T
authors.lastname: Nagata
authors.forename: Tadayasu
authors.initials: T
authors.lastname: Togawa
authors.forename: Takahiro
authors.initials: T
authors.lastname: Tsukimura
authors.forename: Sachiko
authors.initials: S
authors.lastname: Kyogoku
authors.forename: Hideki
authors.initials: H
authors.lastname: Ohshima
authors.forename: Tomoko
authors.initials: T
authors.lastname: Minami
authors.forename: Yusuke
authors.initials: Y
authors.lastname: Sugi
authors.forename: Hitoshi
authors.initials: H
authors.lastname: Sakuraba
authors.forename: Tsutomu
authors.initials: T
authors.lastname: Imaizumi
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D015415:Biomarkers / Q000097:blood; D000795:Fabry Disease / Q000175:diagnosis* / Q000201:enzymology* / Q000453:epidemiology; D006801:Humans; D017379:Hypertrophy, Left Ventricular / Q000175:diagnosis* / Q000201:enzymology* / Q000453:epidemiology; D008297:Male; D008403:Mass Screening / Q000379:methods; D008875:Middle Aged; D000519:alpha-Galactosidase / Q000097:blood*
chemical_list: D015415:Biomarkers; D000519:alpha-Galactosidase